Biology Smart Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Capsule Endoscopy, Drug Delivery, and Patient Monitoring); Application (Imaging, and Monitoring); Disease Indication (Esophageal Diseases, Small Bowel Diseases, Colon Diseases, and Others), and geography
Report Code: TIPRE00018291 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Biology smart pills consist of ingestible sensors which record various physiological measures within the body. These pills have emerged as revolutionary technology innovation that has bridged the gap between healthcare and digital technology. Physicians prefer biology smart pills as these enable real-time patient monitoring via remote controlling options. These are majorly available in the form of a capsule and includes small sensor patch, application on the mobile device, and a provider portal. Once swallowed it activates in the gut and the senor present in the capsule provides the user or the patient with health parameters and the medication effectiveness for more informed healthcare decision and optimized therapies.
MARKET DYNAMICS
Factors driving the growth of biology smart pills market is the rising incidences of diseases such colorectal cancer and gastrointestinal disorders, and growing FDA approvals and CE Mark for biology smart pills. However, technological limitations and risks associated with the capsule endoscopy procedures is expected to hamper the growth of the market. Moreover increasing number of clinical trials globally and geographical reach by major market players is anticipated to create growth opportunities in the market.
MARKET SCOPE
The "Biology Smart Pills Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biology smart pills market with detailed market segmentation by type, application, and disease indication. The biology smart pills market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biology smart pills market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biology smart pills market is segmented on the basis of type, application, and disease indication. On the basis of type, the market is categorized as capsule endoscopy, drug delivery, and patient monitoring. On the basis of application, the market is categorized as imaging, and monitoring. On the basis of diseases indication, the market is categorized as esophageal diseases, small bowel diseases, colon diseases, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biology smart pills market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biology smart pills market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biology smart pills market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biology smart pills market in these regions.
The report covers key developments in the biology smart pills market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biology smart pills market are anticipated to have lucrative growth opportunities in the future with the rising demand for biology smart pills in the global market. Below mentioned is the list of few companies engaged in the biology smart pills market.
The report also includes the profiles of key players in biology smart pills market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Biology smart pills consist of ingestible sensors which record various physiological measures within the body. These pills have emerged as revolutionary technology innovation that has bridged the gap between healthcare and digital technology. Physicians prefer biology smart pills as these enable real-time patient monitoring via remote controlling options. These are majorly available in the form of a capsule and includes small sensor patch, application on the mobile device, and a provider portal. Once swallowed it activates in the gut and the senor present in the capsule provides the user or the patient with health parameters and the medication effectiveness for more informed healthcare decision and optimized therapies.
MARKET DYNAMICS
Factors driving the growth of biology smart pills market is the rising incidences of diseases such colorectal cancer and gastrointestinal disorders, and growing FDA approvals and CE Mark for biology smart pills. However, technological limitations and risks associated with the capsule endoscopy procedures is expected to hamper the growth of the market. Moreover increasing number of clinical trials globally and geographical reach by major market players is anticipated to create growth opportunities in the market.
MARKET SCOPE
The "Biology Smart Pills Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biology smart pills market with detailed market segmentation by type, application, and disease indication. The biology smart pills market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biology smart pills market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biology smart pills market is segmented on the basis of type, application, and disease indication. On the basis of type, the market is categorized as capsule endoscopy, drug delivery, and patient monitoring. On the basis of application, the market is categorized as imaging, and monitoring. On the basis of diseases indication, the market is categorized as esophageal diseases, small bowel diseases, colon diseases, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biology smart pills market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biology smart pills market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biology smart pills market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biology smart pills market in these regions.
The report covers key developments in the biology smart pills market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biology smart pills market are anticipated to have lucrative growth opportunities in the future with the rising demand for biology smart pills in the global market. Below mentioned is the list of few companies engaged in the biology smart pills market.
The report also includes the profiles of key players in biology smart pills market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
- Medimetrics
- Capsovision
- Karl Storz Gmbh & Co. KG
- Fujifilm Holdings Corporation
- Given Imaging
- Proteus Digital Health
- Olympus Corporation
- GE Healthcare
- Boston Scientific Corporation
- Bio-Images Research
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Medimetrics
2. Capsovision
3. Karl Storz Gmbh & Co. KG
4. Fujifilm Holdings Corporation
5. Given Imaging
6. Proteus Digital Health
7. Olympus Corporation
8. GE Healthcare
9. Boston Scientific Corporation
10. Bio-Images Research
1. Medimetrics
2. Capsovision
3. Karl Storz Gmbh & Co. KG
4. Fujifilm Holdings Corporation
5. Given Imaging
6. Proteus Digital Health
7. Olympus Corporation
8. GE Healthcare
9. Boston Scientific Corporation
10. Bio-Images Research
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount